查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530783

2030 年兒科醫療保健市場預測：按產品類型、疾病類型、服務類型、治療類型、最終用戶和地區進行的全球分析

Pediatric Healthcare Market Forecasts to 2030 - Global Analysis By Product Type, Disease Type, Service Type, Treatment Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球兒科醫療保健市場規模將達到 144 億美元，預計到 2030 年將達到 209 億美元，預測期內複合年成長率為 6.4%。

兒科保健是指為兒童和青少年從嬰幼兒到青春期提供的醫療保健和治療。它包括廣泛的服務，包括預防保健、疾病診斷和治療、慢性病管理以及發育和行為評估。目的是維持年輕患者最佳的身體、情緒和心理健康。兒科保健專業人員接受過培訓，可以滿足不同發展階段兒童的獨特需求。

根據觀察者研究基金會2021年12月發布的資料，印度約有2億人營養不良。根據 Genworth 護理成本調查，私人住宅的專業護理服務平均費用為每天 290 美元，半私人房間的費用為每天 255 美元。

提高認知並讓家長參與

市場意識的提高和家長的參與導致兒童健康結果的顯著改善。家長們越來越了解預防保健、疫苗接種和疾病早期發現的重要性。這種積極主動的方法正在推動對小兒科服務、健康計劃和專業護理的需求。此外，父母擴大參與有關孩子醫療保健的決策，要求高品質的醫療建議和整體照護選擇。

小兒科短缺

小兒科的短缺限制了獲得兒科專業護理的機會，並對市場產生了負面影響。這種短缺導致等待時間更長、診斷延遲，並增加了普通小兒科處理複雜病例的壓力。因此，兒童可能無法得到最佳治療，他們的健康狀況可能會惡化。專家的短缺也給現有專家帶來了壓力，導致倦怠和護理品質下降。總的來說，它們阻礙了我們為年輕患者提供全面、及時的醫療保健的能力。

擴大醫療基礎設施

擴大醫療基礎設施將有助於解決市場上小兒科的短缺問題。透過建造更多的醫院、診所和培訓設施，醫療保健系統可以提高教育和僱用小兒科的能力。這種擴展也將改善服務欠缺地區獲得先進診斷工具和專業服務的機會。此外，遠端醫療和數位健康平台可以擴大現有專家的執業範圍，讓更多的兒童獲得所需的照護。

兒科醫療費用高

兒科醫療保健成本的上升給許多家庭造成了獲得醫療服務的障礙，並對市場產生了負面影響。諮詢、治療和專業服務的費用不斷上漲，給一些家長帶來了經濟壓力，導致他們推遲或放棄對孩子進行必要的治療。這可能會導致健康狀況惡化和更多的急診就診，從長遠來看，這可能會帶來高昂的代價。經濟負擔也會阻礙父母尋求預防性醫療保健，進而影響孩子的整體健康和福祉。

COVID-19 的影響：

COVID-19 對兒科醫療保健市場產生了重大影響，擾亂了常規臨床護理、免疫接種和選擇性手術。對感染的恐懼導致醫院就診次數減少，重要治療和預防服務也出現延誤。此外，疫情也導致醫療資源緊張，並轉移了兒科醫療服務的注意力和資金。整體影響包括兒童健康狀況惡化以及醫療保健提供者和系統的壓力增加。

預計在預測期內，慢性病領域將是最大的。

預計慢性病細分市場將成為預測期內最大的細分市場。慢性病的增加使醫療資源緊張，需要採取多學科的治療方法。早期診斷、持續監測和協調護理對於有效管理這些疾病至關重要。慢性病的流行也凸顯了製定全面醫療保健政策以及改善獲得小兒科和支援服務的必要性。

行為治療領域預計在預測期內複合年成長率最高

行為治療產業預計在預測期內複合年成長率最高。人們對心理健康重要性的日益認知增加了對這些服務的需求。行為療法幫助兒童培養應對技能、改善社交互動並有效管理行為。隨著人們對心理健康問題的認知和接受程度的提高，兒科行為治療市場不斷擴大，為年輕患者提供量身定做的支持。

比最大的地區

在先進的醫療技術、優質的醫療基礎設施和全面的保險體系的推動下，預計北美將在預測期內佔據最大的市場佔有率。該地區擁有完善的兒科專家和醫療機構網路，提供從預防性護理到專業治療的全面服務。人們對兒科健康問題的認知不斷提高，加上對小兒科研究和技術創新的投資不斷增加，正在進一步推動市場成長。

複合年成長率最高的地區：

由於醫療基礎設施的擴張，預計亞太地區在預測期內將保持最高的複合年成長率。各國政府和私營部門正在對醫療保健設施進行大量投資，包括兒童醫院和診所，以更有效地滿足年輕患者的需求。改善獲得醫療保健服務（包括免疫接種和例行檢查）的機會正在改善兒童的整體健康。此外，遠端醫療和數位健康解決方案的興起使兒科護理變得更加容易，尤其是在偏遠地區。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球兒科醫療保健市場：依產品類型

  • 診斷設備
  • 監控裝置
  • 實驗設備
  • 點滴幫浦
  • 兒科矯正器
  • 其他產品類型

第6章全球兒科醫療保健市場：依疾病類型

  • 感染疾病
  • 慢性疾病
  • 血液疾病
  • 遺傳疾病
  • 呼吸系統疾病
  • 胃腸道疾病
  • 心血管疾病
  • 其他疾病類型

第7章全球兒科醫療保健市場：依服務類型

  • 住院治療
  • 門診治療
  • 緊急服務
  • 復健服務
  • 家庭保健
  • 安寧療護與臨終關懷

第8章全球兒科醫療保健市場：依治療類型

  • 藥物和治療
  • 手術和醫療程序
  • 放射治療
  • 物理治療及職能治療
  • 行為療法
  • 飲食和營養治療
  • 基因治療

第9章 全球兒科醫療保健市場：依最終用戶分類

  • 醫院
  • 小兒科診所
  • 家庭護理設置
  • 調查機構
  • 其他最終用戶

第10章全球兒科醫療保健市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • Johnson & Johnson
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Eli Lilly and Company
  • AstraZeneca plc
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Limited
  • Novo Nordisk A/S
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim GmbH
  • Hikma Pharmaceuticals PLC
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
Product Code: SMRC26895

According to Stratistics MRC, the Global Pediatric Healthcare Market is accounted for $14.4 billion in 2024 and is expected to reach $20.9 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Pediatric healthcare is the medical care and treatment provided to children and adolescents, from infancy through adolescence. It encompasses a wide range of services, including preventive health care, diagnosis and treatment of illnesses, management of chronic conditions, and developmental and behavioral assessments. The goal is to ensure the optimal physical, emotional, and mental health of young patients. Pediatric healthcare professionals are trained to address the unique needs of children at different stages of development.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. According to the Genworth Cost of Care Survey, skilled nursing services in private homes cost an average of $290 per day, while semi-private homes cost an average of $255.

Market Dynamics:

Driver:

Increasing awareness and parental involvement

Increasing awareness and parental involvement in the market have led to significant improvements in child health outcomes. Parents are now more informed about preventive care, vaccinations, and the importance of early detection of illnesses. This proactive approach has increased demand for pediatric services, wellness programs, and specialized care. Additionally, parents are actively engaging in decision-making regarding their child's healthcare, seeking quality medical advice and holistic care options.

Restraint:

Shortage of pediatric specialists

The shortage of pediatric specialists negatively impacts the market by limiting access to specialized care for children. This scarcity leads to longer wait times, delays in diagnosis and increased pressure on general pediatricians to manage complex cases. Consequently, children may experience suboptimal care and worsened health outcomes. The shortage also burdens existing specialists, leading to burnout and decreased quality of care. Overall, it hinders the ability to provide comprehensive and timely medical attention to young patients.

Opportunity:

Expanding healthcare infrastructure

Expanding healthcare infrastructure can help address the shortage of pediatric specialists in the market. By building more hospitals, clinics, and training facilities, healthcare systems can increase the capacity to educate and employ pediatric specialists. This expansion can also improve access to advanced diagnostic tools and specialized services in underserved areas. Additionally, telemedicine and digital health platforms can extend the reach of existing specialists, ensuring more children receive the necessary care.

Threat:

High cost of pediatric care

The high cost of pediatric care negatively impacts the market by creating barriers to access for many families. Rising costs for consultations, treatments, and specialized services can lead to financial strain, causing some parents to delay or forego necessary care for their children. This can result in worsening health conditions and increased emergency visits, which are more costly in the long run. The financial burden may also deter parents from seeking preventive care, ultimately affecting children's overall health and well-being.

Covid-19 Impact:

COVID-19 significantly impacted the pediatric healthcare market, causing disruptions in routine care, vaccinations, and elective procedures. Fear of exposure led to decreased hospital visits, delaying critical care and preventive services. Additionally, the pandemic strained healthcare resources, diverting attention and funding away from pediatric services. The overall impact includes worsened health outcomes for children and increased stress on healthcare providers and systems.

The chronic diseases segment is expected to be the largest during the forecast period

The chronic diseases is expected to be the largest during the forecast period. The rise in chronic illnesses strains healthcare resources and necessitates a multidisciplinary approach to treatment. Early diagnosis, continuous monitoring, and coordinated care are crucial for managing these conditions effectively. The prevalence of chronic diseases also highlights the need for comprehensive healthcare policies and improved access to pediatric specialists and support services.

The behavioral therapy segment is expected to have the highest CAGR during the forecast period

The behavioral therapy segment is expected to have the highest CAGR during the forecast period. The growing recognition of mental health's importance has increased demand for these services. Behavioral therapy helps children develop coping skills, improve social interactions, and manage behaviors effectively. As awareness and acceptance of mental health issues rise, the market for pediatric behavioral therapy continues to expand, offering tailored support for young patients.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by advanced medical technologies, high-quality healthcare infrastructure, and strong insurance coverage. The region has a well-established network of pediatric specialists and healthcare facilities, offering comprehensive services from preventive care to specialized treatments. Rising awareness of child health issues, coupled with increasing investment in pediatric research and innovation, further fuels market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to expanding healthcare infrastructure. Governments and private sectors are investing heavily in healthcare facilities, including children's hospitals and clinics, to address the needs of young patients more effectively. Enhanced access to healthcare services, including vaccinations and routine check-ups, is improving overall child health outcomes. Additionally, the rise of telemedicine and digital health solutions is making pediatric care more accessible, particularly in remote areas.

Key players in the market

Some of the key players in Pediatric Healthcare market include Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis International AG, Merck & Co., Inc., Sanofi, GlaxoSmithKline plc, AbbVie Inc., Eli Lilly and Company, AstraZeneca plc, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Bristol-Myers Squibb Company, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd. and Mylan N.V.

Key Developments:

In April 2024, Novartis announced that the U.S. Food and Drug Administration (FDA) approved Lutathera(R) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs.

In April 2024, Pfizer Inc announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at Higher Risk of Severe Illness),evaluating a single dose of ABRYSVO versus placebo in adults 18 to 59 years of age

Product Types Covered:

  • Diagnostic Devices
  • Monitoring Devices
  • Laboratory Equipment
  • Infusion Pumps
  • Pediatric Braces
  • Other Product Types

Disease Types Covered:

  • Infectious Diseases
  • Chronic Diseases
  • Hematological Disorders
  • Genetic Disorders
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Cardiovascular Disorders
  • Other Disease Types

Service Types Covered:

  • Inpatient Care
  • Outpatient Care
  • Emergency Services
  • Rehabilitation Services
  • Home Healthcare
  • Palliative and Hospice Care

Treatment Types Covered:

  • Medication and Therapeutics
  • Surgery and Medical Procedures
  • Radiation Therapy
  • Physical and Occupational Therapy
  • Behavioral Therapy
  • Dietary and Nutritional Therapy
  • Gene Therapy

End Users Covered:

  • Hospitals
  • Pediatric Clinics
  • Home Care Settings
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Healthcare Market, By Product Type

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
  • 5.3 Monitoring Devices
  • 5.4 Laboratory Equipment
  • 5.5 Infusion Pumps
  • 5.6 Pediatric Braces
  • 5.7 Other Product Types

6 Global Pediatric Healthcare Market, By Disease Type

  • 6.1 Introduction
  • 6.2 Infectious Diseases
  • 6.3 Chronic Diseases
  • 6.4 Hematological Disorders
  • 6.5 Genetic Disorders
  • 6.6 Respiratory Disorders
  • 6.7 Gastrointestinal Disorders
  • 6.8 Cardiovascular Disorders
  • 6.9 Other Disease Types

7 Global Pediatric Healthcare Market, By Service Type

  • 7.1 Introduction
  • 7.2 Inpatient Care
  • 7.3 Outpatient Care
  • 7.4 Emergency Services
  • 7.5 Rehabilitation Services
  • 7.6 Home Healthcare
  • 7.7 Palliative and Hospice Care

8 Global Pediatric Healthcare Market, By Treatment Type

  • 8.1 Introduction
  • 8.2 Medication and Therapeutics
  • 8.3 Surgery and Medical Procedures
  • 8.4 Radiation Therapy
  • 8.5 Physical and Occupational Therapy
  • 8.6 Behavioral Therapy
  • 8.7 Dietary and Nutritional Therapy
  • 8.8 Gene Therapy

9 Global Pediatric Healthcare Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Pediatric Clinics
  • 9.4 Home Care Settings
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Pediatric Healthcare Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Pfizer Inc.
  • 12.3 Roche Holding AG
  • 12.4 Novartis International AG
  • 12.5 Merck & Co., Inc.
  • 12.6 Sanofi
  • 12.7 GlaxoSmithKline plc
  • 12.8 AbbVie Inc.
  • 12.9 Eli Lilly and Company
  • 12.10 AstraZeneca plc
  • 12.11 Astellas Pharma Inc.
  • 12.12 Takeda Pharmaceutical Company Limited
  • 12.13 Novo Nordisk A/S
  • 12.14 Bristol-Myers Squibb Company
  • 12.15 Amgen Inc.
  • 12.16 Gilead Sciences, Inc.
  • 12.17 Boehringer Ingelheim GmbH
  • 12.18 Hikma Pharmaceuticals PLC
  • 12.19 Teva Pharmaceutical Industries Ltd.
  • 12.20 Mylan N.V.

List of Tables

  • Table 1 Global Pediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Pediatric Healthcare Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Pediatric Healthcare Market Outlook, By Diagnostic Devices (2022-2030) ($MN)
  • Table 4 Global Pediatric Healthcare Market Outlook, By Monitoring Devices (2022-2030) ($MN)
  • Table 5 Global Pediatric Healthcare Market Outlook, By Laboratory Equipment (2022-2030) ($MN)
  • Table 6 Global Pediatric Healthcare Market Outlook, By Infusion Pumps (2022-2030) ($MN)
  • Table 7 Global Pediatric Healthcare Market Outlook, By Pediatric Braces (2022-2030) ($MN)
  • Table 8 Global Pediatric Healthcare Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Pediatric Healthcare Market Outlook, By Disease Type (2022-2030) ($MN)
  • Table 10 Global Pediatric Healthcare Market Outlook, By Infectious Diseases (2022-2030) ($MN)
  • Table 11 Global Pediatric Healthcare Market Outlook, By Chronic Diseases (2022-2030) ($MN)
  • Table 12 Global Pediatric Healthcare Market Outlook, By Hematological Disorders (2022-2030) ($MN)
  • Table 13 Global Pediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
  • Table 14 Global Pediatric Healthcare Market Outlook, By Respiratory Disorders (2022-2030) ($MN)
  • Table 15 Global Pediatric Healthcare Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
  • Table 16 Global Pediatric Healthcare Market Outlook, By Cardiovascular Disorders (2022-2030) ($MN)
  • Table 17 Global Pediatric Healthcare Market Outlook, By Other Disease Types (2022-2030) ($MN)
  • Table 18 Global Pediatric Healthcare Market Outlook, By Service Type (2022-2030) ($MN)
  • Table 19 Global Pediatric Healthcare Market Outlook, By Inpatient Care (2022-2030) ($MN)
  • Table 20 Global Pediatric Healthcare Market Outlook, By Outpatient Care (2022-2030) ($MN)
  • Table 21 Global Pediatric Healthcare Market Outlook, By Emergency Services (2022-2030) ($MN)
  • Table 22 Global Pediatric Healthcare Market Outlook, By Rehabilitation Services (2022-2030) ($MN)
  • Table 23 Global Pediatric Healthcare Market Outlook, By Home Healthcare (2022-2030) ($MN)
  • Table 24 Global Pediatric Healthcare Market Outlook, By Palliative and Hospice Care (2022-2030) ($MN)
  • Table 25 Global Pediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 26 Global Pediatric Healthcare Market Outlook, By Medication and Therapeutics (2022-2030) ($MN)
  • Table 27 Global Pediatric Healthcare Market Outlook, By Surgery and Medical Procedures (2022-2030) ($MN)
  • Table 28 Global Pediatric Healthcare Market Outlook, By Radiation Therapy (2022-2030) ($MN)
  • Table 29 Global Pediatric Healthcare Market Outlook, By Physical and Occupational Therapy (2022-2030) ($MN)
  • Table 30 Global Pediatric Healthcare Market Outlook, By Behavioral Therapy (2022-2030) ($MN)
  • Table 31 Global Pediatric Healthcare Market Outlook, By Dietary and Nutritional Therapy (2022-2030) ($MN)
  • Table 32 Global Pediatric Healthcare Market Outlook, By Gene Therapy (2022-2030) ($MN)
  • Table 33 Global Pediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Pediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 35 Global Pediatric Healthcare Market Outlook, By Pediatric Clinics (2022-2030) ($MN)
  • Table 36 Global Pediatric Healthcare Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 37 Global Pediatric Healthcare Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 38 Global Pediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.